06R84KZ
Replacement Portal Vein to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 6 Lower Veins |
| Operation | R Replacement |
| Body Part | 8 Portal Vein |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
This family covers procedures where a diseased or damaged segment of a lower-body vein - in the leg, pelvis, or abdomen - is physically removed and replaced with another material that takes over its job of carrying blood back toward the heart. The replacement material can be a graft harvested from the patient's own body, tissue from a donor or animal source that has been processed for implantation, or a synthetic conduit made from materials like expanded PTFE. It is most often considered when a vein segment is too scarred, obstructed, or aneurysmal to repair in place.
Surgeons turn to this approach in situations such as reconstructing a badly damaged femoral or iliac vein after trauma, cancer resection that required removing a vein along with a tumor, or chronic venous disease that has destroyed a segment beyond salvage. The goal is to restore a functioning channel for venous return rather than simply tying off the vessel, which can be important for preventing long-term swelling and pressure buildup in the limb.
Because deep veins carry a large volume of blood at low pressure, these reconstructions are technically demanding and are typically reserved for cases where the alternative - vein ligation or leaving the segment untreated - would cause significant disability.
Anatomy & Axis Detail
Portal Vein
The portal vein is the major conduit carrying nutrient-rich blood from the splenic and superior mesenteric veins to the liver, and its replacement is a critical step in pancreatic head resections, liver transplantation, and management of portal vein thrombosis, where the vessel is often invaded by adjacent tumor or occluded by clot. Reconstruction with a venous or synthetic graft restores hepatic portal perfusion, which is essential for liver function and is a determining factor in whether a tumor is considered resectable. Because the portal vein's patency directly affects graft or organ survival in transplantation and resection settings, documentation should capture the extent of vein resected and the specific graft technique employed.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
A code from this family requires documentation that a vein segment was excised or entirely taken out of the body and replaced with graft material, not simply patched, bypassed, or reinforced on its outer surface. The operative note should specify the exact vein involved (e.g., common femoral vein versus external iliac vein) and the type of material used, since device value selection depends on whether the graft is autologous tissue, nonautologous tissue, or synthetic.
The most common assignment error is confusing Replacement with Supplement or Bypass. If the native vein is left in place and the graft material is only added to reinforce or widen it, Supplement applies instead. If the graft creates an alternate route around a blocked segment while the diseased vein remains, that is a Bypass procedure, not Replacement. Coders should also confirm the qualifier for autologous versus nonautologous tissue, which is frequently omitted or guessed rather than confirmed from the documentation.